← Back to all signals
RESEARCH PAPER ANALYSIS

Study on the effects and mechanisms of rhythmic auditory stimulation on freezing of gait in Parkinson's disease: investigation based on functional near-infrared spectroscopy (fNIRS) technology.

AI interpretation is pending for this paper.

PMID42211308
JournalFrontiers in neurology
Publication Date2026-01-01
Ingested2026-05-29 04:00 PM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

INTRODUCTION: Freezing of gait (FOG) in Parkinson's disease (PD) patients is a critical determinant of motor impairment and fall risk. Rhythmic auditory stimulation (RAS) has been shown to ameliorate FOG symptoms, although the underlying neurophysiological mechanisms are not fully understood. OBJECTIVES: This research employed functional near-infrared spectroscopy (fNIRS) to analyze three RAS-two external auditory cueing strategies (beat perception and music therapy) and one internal cueing method (mental beat imagery)-to examine gait parameters and cortical activation patterns in Parkinson's disease patients with freezing of gait (PD + FOG) compared to healthy controls (HC). The study also sought to evaluate the therapeutic effectiveness of these rhythm-based interventions in alleviating FOG episodes. METHODS: Twenty-eight patients with PD + FOG and twenty-eight age-matched HC were enrolled in the study. Gait analysis was performed during narrow corridor ambulation, designed to induce freezing episodes, and during straight-line walking in an open environment. fNIRS was employed to measure fluctuations in oxygenated hemoglobin (HbO2) and deoxygenated hemoglobin (HHb) concentrations, serving as indicators of cortical activation. Regions of interest (ROIs) included the prefrontal cortex (PFC), premotor cortex (PMC), and temporal cortex (TLC). Intracortical functional connectivity during each locomotor task was evaluated through correlation analyses of HbO2 signals between the ROIs. RESULTS: PD + FOG patients exhibited gait disturbances characterized by reduced gait velocity and stride length, along with increased mediolateral postural sway during freezing episodes. Neuroimaging indicated significantly decreased activation in the primary somatosensory cortex (S1), PMC, and PFC compared to healthy controls, despite elevated intracortical connectivity involving indirect corticospinal pathways. Differential responses to RAS interventions were noted: rhythmic auditory cues enhanced connectivity between TLC and PMC; music therapy significantly improved PFC intrinsic connectivity; whereas imagined auditory cues potentially impaired sensorimotor integration due to excessive reliance on internal cognitive mechanisms. CONCLUSION: Various RAS pathways can ameliorate freezing of gait symptoms by selectively modulating functional connectivity between the prefrontal cortex and sensorimotor circuits. The underlying neural mechanisms may largely involve neural entrainment and reorganization of brain networks. These results offer vital empirical insights into the pathophysiology of gait freezing and provide a preliminary theoretical basis for designing precision neuromodulation interventions.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 The cGAS-STING-Glymphatic-gut Axis in Parkinson's disease: A proposed self-amplifying triad of Neuroinflammation and therapeutic opportunity. International immunopharmacology 91.0 2 Immunosenescence and Inflammaging as Drivers of Neurodegeneration: Cellular Mechanisms, Neuroimmune Crosstalk, and Therapeutic Implications. Cells 91.0 3 Flavonoids improve neurotransmitters for Parkinson's treatment: mechanism and therapeutic potential. Frontiers in pharmacology 88.0 4 Alpha-Lipoic Acid and Biotin in Neurodegenerative Diseases: Convergent Mechanistic Insights from Preclinical Models to Clinical Perspectives. Neurology international 78.0 5 The Gut Microbiota in Parkinson's Disease: Mechanistic Insights into Microbial-Host Interactions. Microorganisms 85.0 6 Linking inflammation, metabolic dysfunction, and neurodegeneration: a comprehensive review of TLR2 pathways in type 2 diabetes. Frontiers in clinical diabetes and healthcare 80.0 7 Neuroprotective effects of GLP-2 and a GLP-2/GIP dual receptor agonist in an MPTP-induced mouse model of Parkinson's disease. Peptides 86.0 8 TNF alpha unmasks enteric malate aspartate shuttle dysfunction bridging Parkinson disease and intestinal inflammation. Nature communications 91.5 9 Lipid Metabolism and Neurodegeneration: Mechanistic Insights and Therapeutic Targets. Ageing research reviews 82.0 10 Shared functional microbiome signatures in Parkinson's disease and constipation predominate irritable bowel syndrome despite taxonomic divergence. Brain, behavior, & immunity - health 80.0 11 Benzimidazole as a Versatile Scaffold for Developing Neurotherapeutics Against Neurodegenerative Diseases. ChemMedChem 74.0 12 Biomimicking neuromelanin reverses the gait deficits and dopaminergic neuronal loss in the Parkinson's disease. Colloids and surfaces. B, Biointerfaces 86.0 13 Neuroprotective roles of klotho: Molecular pathways and therapeutic implications for cognitive health in neurological and psychiatric diseases. Experimental physiology 84.0 14 Flavonoid Rutin Reduces Intestinal Inflammation in an Experimental Model of Parkinson's Disease. Neurotoxicity research 70.0 15 Nanostructured Lipid Carriers Enhance Brain Delivery and Antioxidant Efficacy of a Small-Molecule MAO B Inhibitor for Neurodegenerative Disease Therapy. Molecular pharmaceutics 78.0 16 Pathophysiological Role of the Gut Brain Axis in Parkinson's Disease: From Microbial Metabolites and Intestinal Permeability to Central Neuroinflammation. Current neurovascular research 86.0 17 Parkinson's Disease: From Metabolism to Genetics-A Comprehensive Review. Current issues in molecular biology 86.0 18 Navigating the cholesterol maze: Key insights on use of statins in neurodegenerative disorders. Neuroprotection (Chichester, England) 76.0 19 Integrative network pharmacology delineates dual GPCR and non-GPCR mechanisms of blended and individual Taikong Blue lavender and Pingyin rose essential oils in neurodegenerative and psychiatric disorders. Computers in biology and medicine 65.0 20 Models of neuroprotection in Parkinson's disease: Exploring cellular, molecular, and microenvironmental targets. Experimental neurology 78.0 21 Hyaluronic acid: emerging roles and biomaterial innovations in Alzheimer's and Parkinson's disease therapy. Frontiers in pharmacology 75.2 22 Molecular mechanisms underlying Parkinson's disease and role of phytochemicals, α-synuclein, sirtuins, and incretin mimetics in potential therapy. Frontiers in pharmacology 75.0 23 Lipid droplets in neurodegenerative diseases: pathological drivers and therapeutic vulnerabilities. Cell death discovery 82.0 24 Brain-gut-microbiota axis: a review on the bidirectional regulatory mechanisms between gut microbiota and brain and their disease interactions. Frontiers in microbiology 74.0 25 Long non-coding RNAs in neurodegenerative diseases - Molecular mechanisms, liquid biopsy biomarkers, and therapeutic targets: A review. Biomolecules & biomedicine 84.0 26 Neurosyphilis and Parkinsonism: Overlapping Pathophysiology and Emerging Therapeutic Insights. Current neurovascular research 76.0 27 Molecular biochemistry of soluble epoxide hydrolase in lipid mediator pathways and neuroinflammatory responses. The Journal of steroid biochemistry and molecular biology 82.0 28 Multifaceted role of CNPY2 beyond ER stress: Disease implications and therapeutic potential. Cell stress 83.3 29 Neuroprotective Role of Exercise-based Physiotherapy Combined with Pharmacological Agents in Parkinson's Disease. Central nervous system agents in medicinal chemistry 64.0 30 Distinct metabolomic and proteomic signatures in Parkinson's disease patients with REM sleep behavior disorder. Signal transduction and targeted therapy 84.0 31 HMGB1-mediated neuroinflammation: molecular mechanisms and emerging therapeutic approaches. Inflammopharmacology 78.0 32 Beyond acid-base dyshomeostasis: Dynamic instability of neuronal lysosomal pH as a pathogenic mechanism and therapeutic target in neurological diseases. Biochemical pharmacology 88.0
Neurocompute Parkinson’s Narrative Velocity Infographic
NEUROCOMPUTE VISUAL SYSTEM

Open the Narrative Velocity Map

Explore the full Parkinson’s research intelligence diagram.

Expand Intelligence View →
Full Neurocompute Infographic